ArticleAllergy, asthma & immunology research2026
Diagnostic Role of Aspirin Challenge in NSAID-Exacerbated Respiratory Disease: A Prospective Single-Center Study in China.
Article in Allergy, asthma & immunology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeEpidemiological data on non-steroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) remain unknown in most countries, especially China. Moreover, aspirin challenge tests are not yet routinely used in clinical practice. To address these gaps, this study aimed to evaluate the diagnostic value of the aspirin challenge in identifying N-ERD among Chinese patients with chronic rhinosinusitis with nasal polyps (CRSwNP), using the algorithm proposed by the latest European Academy of Allergy and Clinical Immunology position paper.
methodsPatients with CRSwNP were evaluated through a standardized diagnostic protocol, including clinical history review, intranasal aspirin challenge (IAC), and, if IAC was negative, a subsequent oral aspirin challenge (OAC).
resultsAmong 190 CRSwNP patients (49.5% with asthma), N-ERD was diagnosed in 61 (32.1%). Of these, 19 (10.0%) were diagnosed based on clinical history, while 42 (22.1%) were diagnosed by aspirin challenge. Among challenge-positive patients, 34 reacted to IAC and 8 to OAC. Of the 137 patients with negative IAC results, 129 were tested negative by a subsequent OAC, yielding a negative predictive value of 94.2% (129/137) for IAC in the diagnosis of N-ERD. Mild asthma exacerbations occurred in 3 of 171 patients (1.75%) during IAC, all of whom had moderate-to-severe asthma.
conclusionsThis is the first study to report that 32.1% of Chinese CRSwNP patients were diagnosed with N-ERD when a full diagnostic protocol was applied, compared to 10.0% based on history alone. These findings emphasize the diagnostic value of aspirin challenge and support IAC as an initial tool in the evaluation of N-ERD in CRSwNP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.